Basecamp Wealth Advisors’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320 Buy
74
+1
+1% +$4 ﹤0.01% 1696
2026
Q1
$280 Buy
+73
New +$299 ﹤0.01% 1831

Other funds holding OM

Basecamp Wealth Advisors's OM Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Outset Medical (OM) stake by 1.4% in Q2 2026, buying an estimated $4 and bringing the position to 74 shares worth $320. The position accounts for ﹤0.01% of the portfolio, ranked #1696.

Basecamp Wealth Advisors first reported a position in OM in Q1 2026 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Basecamp Wealth Advisors held 74 shares of Outset Medical worth $320 as of Q2 2026.
  • Basecamp Wealth Advisors bought 1 Outset Medical share in Q2 2026, an estimated $4.
  • Outset Medical made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1696 holding.
  • Basecamp Wealth Advisors first reported a position in Outset Medical in Q1 2026 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.